This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Agar, M. Articles by Murdoch, O. Search for Related Content PubMed PubMed Citation Articles by Agar, M. Articles by Murdoch, O. Social Bookmarking                         What's this?

Buprenorphine: "Field Trials" of a New Drug

magar{at}anth.umd.edu

Philippe Bourgois

Department of Anthropology, History and Social Medicine in the University of San Francisco’s School of Medicine

John French

New Jersey Department of Health

Owen Murdoch

University of Maryland

Buprenorphine is being introduced as a new treatment drug for narcotics addiction in the United States. The authors were asked by the National Institute on Drug Abuse to conduct a field trial to determine if buprenorphine might play a role in street markets. Because no street use of the drug existed in the United States, the authors used three sources of information: (a) "street readings" of clinical studies, (b) Internet discussion lists, and (c) research in other countries. By using an emergent style of analysis that relies on replication of patterns across disparate data sources, it was determined that buprenorphine has desirable characteristics from a street addict point of view. An evaluation of the field trial 5 years later evaluates its accuracy.

Qualitative Health Research, Vol. 11, No. 1, 69-84 (2001)
DOI: 10.1177/104973201129118948


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?